Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma

Journal of Clinical Oncology

Volumn 30, Issue 29, 2012, Pages 3618-3624

  Krull, Kevin R ^a   Sabin, Noah D ^a   Reddick, Wilburn E ^a   Zhu, Liang ^a   Armstrong, Gregory T ^a   Green, Daniel M ^a   Arevalo, Alejandro R ^b   Krasin, Matthew J ^a   Srivastava, Deo Kumar ^a   Robison, Leslie L ^a   Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CARBON MONOXIDE;

ADULT; ARTICLE; ATTENTION; BLOOD FLOW VELOCITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CEREBROVASCULAR ACCIDENT; CHILDHOOD CANCER; COGNITIVE DEFECT; COHORT ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; EXECUTIVE FUNCTION; FEMALE; HEART DISEASE; HODGKIN DISEASE; HUMAN; LEUKOENCEPHALOPATHY; LONG TERM MEMORY; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MITRAL VALVE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE; RESPONSE TIME; SHORT TERM MEMORY; WORKING MEMORY;

ADOLESCENT; ADULT; AGE FACTORS; ANTHRACYCLINES; CENTRAL NERVOUS SYSTEM DISEASES; CHEMORADIOTHERAPY; CHILD; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SEX FACTORS; SURVIVORS; TIME FACTORS;

EID: 84867598843     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.6841     Document Type: Article

References (32)

1. Bowers DC, McNeil DE, Liu Y, et al: Stroke as a late treatment effect of Hodgkin's disease: A report from the Childhood Cancer Survivor Study. J Clin Oncol 23:6508-6515, 2005 (Pubitemid 46190242)
2. Mulrooney DA, Yeazel MW, Kawashima T, et al: Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339:b4606, 2009
3. Mertens AC, Yasui Y, Liu Y, et al: Pulmonary complications in survivors of childhood and adolescent cancer: A report from the Childhood Cancer Survivor Study. Cancer 95:2431-2441, 2002 (Pubitemid 35351152)
4. Jeerakathil T, Wolf PA, Beiser A, et al: Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke 35:1857-1861, 2004 (Pubitemid 38971865)
5. Debette S, Bauters C, Leys D, et al: Prevalence and determinants of cognitive impairment in chronic heart failure patients. Congest Heart Fail 13:205-208, 2007
6. Gorelick PB, Scuteri A, Black SE, et al: Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2672-2713, 2011
7. Kaffashian S, Dugravot A, Nabi H, et al: Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: Evidence from the Whitehall II study. Eur Heart J 32:2326-2332, 2011
8. De Reuck J, Proot P, Van Maele G: Chronic obstructive pulmonary disease as a risk factor for stroke-related seizures. Eur J Neurol 14:989-992, 2007 (Pubitemid 47300771)
9. Sachdev PS, Anstey KJ, Parslow RA, et al: Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord 21:300-308, 2006 (Pubitemid 43735674)
10. Howlander N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD, 2011. http://seer.cancer. gov/csr/1975-2008/
11. Mariotto AB, Rowland JH, Yabroff KR, et al: Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev 18:1033-1040, 2009
12. Hudson MM, Ness KK, Nolan VG, et al: Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer 56:825-836, 2011
13. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004 (Pubitemid 46638624)
14. Lang RM, Bierig M, Devereux RB, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463, 2005 (Pubitemid 41821197)
15. Pellegrino R, Viegi G, Brusasco V, et al: Interpretative strategies for lung function tests. Eur Respir J 26:948-968, 2005 (Pubitemid 41632054)
16. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-187, 1999 (Pubitemid 29036522)
17. Wechsler D: Wechsler Abbreviated Scale of Intelligence. San Antonio, TX, Psychological Corporation, 1999
18. Wechsler D: Wechsler Adult Intelligence Scale-Third Edition. San Antonio, TX, Psychological Corporation, 1997
19. Strauss E, Sherman EM, Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (ed 3). New York, NY, Oxford University Press, 2006
20. Conners CK: Conners' Continuous Performance Test II. North Tonawanda, NY, Multi-Health Systems, 2001
21. Delis DC, Kramer JH, Kaplan E, et al: California Verbal Learning Test-Second Edition. San Antonio, TX, Psychological Corporation, 2000
22. Roth RM, Isquith PK, Gioia GA: Behavior Rating Inventory of Executive Function-Adult Version. Lutz, FL, Psychological Assessment Resources, 2005
23. Mulrooney DA, Ness KK, Neglia JP, et al: Fatigue and sleep disturbance in adult survivors of childhood cancer: A report from the childhood cancer survivor study (CCSS). Sleep 31:271-281, 2008 (Pubitemid 351536529)
24. Smith OR, Michielsen HJ, Pelle AJ, et al: Symptoms of fatigue in chronic heart failure patients: Clinical and psychological predictors. Eur J Heart Fail 9:922-927, 2007 (Pubitemid 47332317)
25. Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 1:79, 2003
26. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al: Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 289:194-202, 2003 (Pubitemid 36068707)
27. Das RR, Seshadri S, Beiser AS, et al: Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39:2929-2935, 2008
28. Kargin R, Esen O, Pala S, et al: The relationship between echocardiographic parameters and brain natriuretic peptide levels in acute and chronic mitral regurgitation. Turk Kardiyol Dern Ars 39:191-197, 2011
29. Daniels LB, Laughlin GA, Kritz-Silverstein D, et al: Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults. Am J Med 124:670.e1-8, 2011
30. Hughes JM, Bates DV: Historical review: The carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell (Theta.Vc) components. Respir Physiol Neurobiol 138:115-142, 2003 (Pubitemid 37376420)
31. Ursino M, Magosso E: Role of tissue hypoxia in cerebrovascular regulation: A mathematical modeling study. Ann Biomed Eng 29:563-574, 2001 (Pubitemid 32779963)
32. Jellinger KA: The pathology of "vascular dementia": A critical update. J Alzheimers Dis 14:107-123, 2008